Irwin Scher
Président chez Opertech Bio, Inc.
Profil
Irwin Scher is currently the Chairman of Opertech Bio, Inc. He previously held positions such as President & Chief Executive Officer at Biosynexus, Inc., Chief Executive Officer at Astra Zeneca Oy, Director at Clarient, Inc. and Intarcia Therapeutics, Inc., and Senior VP-Drug Development & Medical Affairs at AstraZeneca PLC and Astra Merck, Inc. He was also the VP-Global Clinical Research & Development at Merck KGaA.
Scher has a background in medicine and has worked as a Professor of Medicine at the Uniformed Services University of the Health Sciences and as the Head of the Immunology Branch at the Naval Medical Research Institute.
He received his undergraduate degree from the State University of New York at Albany and his doctorate from Albert Einstein College of Medicine, Inc.
Postes actifs de Irwin Scher
| Sociétés | Poste | Début |
|---|---|---|
Opertech Bio, Inc.
 Opertech Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Opertech Bio, Inc. provides taste testing solutions for food, beverage, flavor ingredients, pet food, and pharmaceutical industries. Its technology can be used to discover new flavor ingredients, measure palatability, and optimize flavor formulations. The firm has developed taste evaluation technology called Microtiter Operant Gustometer, or MOG, an automated high throughput system for rapid characterization of taste sensory properties. The company was founded by Scott M. Horvitz and R. Kyle Palmer and is headquartered in Philadelphia, PA. | Président | - |
Anciens postes connus de Irwin Scher
| Sociétés | Poste | Fin |
|---|---|---|
| REDPOINT BIO CORPORATION | Directeur/Membre du Conseil | 25/08/2011 |
Clarient, Inc.
 Clarient, Inc. Medical/Nursing ServicesHealth Services Clarient, Inc. provides cancer diagnostic testing services. It offers oncology diagnostic testing services to community pathologists, oncologists, biopharmaceutical companies, and researchers. The company was founded in 1993 and is headquartered in Aliso Viejo, CA. | Directeur/Membre du Conseil | 27/06/2007 |
| MERCK KGAA | Directeur Technique/Scientifique/R&D | - |
Astra Zeneca Oy
 Astra Zeneca Oy Miscellaneous Commercial ServicesCommercial Services Astra Zeneca Oy engages in the development and manufacture of biopharmaceutical products. It specializes in clinical drug research in oncology, diabetes, and cardiovascular diseases. The company was founded on March 19, 1965 and is headquartered in Espoo, Finland. | Directeur Général | 01/01/2005 |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Corporate Officer/Principal | 01/08/1999 |
Formation de Irwin Scher
| State University of New York at Albany | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| MERCK KGAA | Health Technology |
| COGNITION THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Clarient, Inc.
Clarient, Inc. Medical/Nursing ServicesHealth Services Clarient, Inc. provides cancer diagnostic testing services. It offers oncology diagnostic testing services to community pathologists, oncologists, biopharmaceutical companies, and researchers. The company was founded in 1993 and is headquartered in Aliso Viejo, CA. | Health Services |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Health Technology |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |
Redpoint Bio Corp.
 Redpoint Bio Corp. Food: Specialty/CandyConsumer Non-Durables Redpoint Bio Corp. is a development stage biotechnology company, which engages in the discovery and development of novel taste modulators for the food, beverage, and pharmaceutical industries. The company was founded by Robert F. Margolskee and Shawn M. Marcell in August 1995 and headquartered in Philadelphia, PA. | Consumer Non-Durables |
| Naval Medical Research Institute | |
Astra Zeneca Oy
Astra Zeneca Oy Miscellaneous Commercial ServicesCommercial Services Astra Zeneca Oy engages in the development and manufacture of biopharmaceutical products. It specializes in clinical drug research in oncology, diabetes, and cardiovascular diseases. The company was founded on March 19, 1965 and is headquartered in Espoo, Finland. | Commercial Services |
Opertech Bio, Inc.
Opertech Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Opertech Bio, Inc. provides taste testing solutions for food, beverage, flavor ingredients, pet food, and pharmaceutical industries. Its technology can be used to discover new flavor ingredients, measure palatability, and optimize flavor formulations. The firm has developed taste evaluation technology called Microtiter Operant Gustometer, or MOG, an automated high throughput system for rapid characterization of taste sensory properties. The company was founded by Scott M. Horvitz and R. Kyle Palmer and is headquartered in Philadelphia, PA. | Commercial Services |
